Global Circulating Tumor Cell Market Analysis and Forecast, 2022-2028
The global circulating tumor cell market is expected to grow at a CAGR of 10.5% over the forecast period of 2022-2028.
Market Scope & Overview
The global circulating tumor cell market study comprises comprehensive market analysis and insights across the key market segments and geography. The market report analyzes the global market for the historical period of 2019-2021 and the forecast period of 2022-2028 based on the product installed base, key forecasting factors impacting the market conditions, and major market developments happening in the market throughout the analysis period. practices primary and secondary research for conducting an insightful market study. Various market parameters such as macroeconomic conditions, market environment, government policies, and competitive landscape are thoroughly studied and taken into account while analyzing the market.
The global circulating tumor cell market report also covers value chain and supply chain analysis that provides in-depth information about the value addition at each stage of the product. Market dynamics incorporated in the market study include drivers, restraints/challenges, trends, and their impact on the market throughout the analysis period.
The global circulating tumor cell market includes a market share analysis and market structure overview with detailed company profiling of leading players with their financials, product offerings, major developments, etc. This enables, clients and report buyers to make strong, precise, and timely decisions.
State of Global Economy, COVID-19 Outbreak, and the Russo-Ukraine War Impact
The global economy experienced heavy headwinds, throughout 2019-2021, as some countries witnessed subdue growth, while other countries continued to grapple with economic slowdowns. Also, intensifying tension between the US and Iran along with the tightening sanctions on Venezuela by the US further hampered global economic growth in 2019. Moreover, the heightened trade war between the US and China and the rising trade uncertainty continued to exert adverse effects on the global economy. Amid all these, the COVID-19 outbreak at the end of the year 2019 in Wuhan, China further deteriorated global economic growth.
The COVID-19 pandemic has levied undue pressure across the majority of industries globally and has caused a major economic crisis in the US, India, Italy, UK, Germany, India, Japan, South Korea, the UK, and many others. Many of these countries had announced partial or complete nationwide lockdowns. The governments of several nations have called on people to shelter in place at home, travel restrictions, shut down local businesses, and prohibited social gatherings.
The rapid spread of the virus in the early month of 2020 followed by a second wave of COVID-19 caused a significant change in management strategies of the leading industries which have affected the market or industry at a significant level. Besides, the exit of the UK from the European Union earlier in 2020 and the Russo-Ukraine war in 2022 exacerbated the ever-heightened global uncertainty.
Key Market Segmentation and Companies
has segmented the global circulating tumor cell market based on technology, application, end users, and region.
• By Technology
o CTC Detection and Enrichment method
• Immunocapture
• Size Based Separation
• Density-Based Separation
• Combined Methods
• Others
o CTC Direct Detection Methods
• SERS
• Microscopy
• Others
o CTC Analysis
• By Application
o Clinical
o Research
• By End Users
o Hospitals and Clinics
o Diagnostic Centers
o Others
• By Region
o North America
• US
• Canada
o Latin America
• Brazil
• Mexico
• Rest of Latin America
o Western Europe
• Germany
• UK
• France
• Spain
• Italy
• Benelux
• Nordic
• Rest of Western Europe
o Eastern Europe
• Russia
• Poland
• Rest of Eastern Europe
o Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• ASEAN (Indonesia, Vietnam, Malaysia, etc.)
• Rest of Asia Pacific
o Middle East & Africa
• GCC
• South Africa
• Turkey
• Rest of the Middle East & Africa
• Leading Companies and Market Players
o Miltenyi Biotec
o Precision Medicine Group LLC
o Menarini Group
o SRI International, Biocept
o Inc., QIAGEN, Greiner AG
o Sysmex Corporation
o Thermo Fisher Scientific Inc.
o STEMCELL Technologies Inc.
Global Circulating Tumor Cell Market Analysis and Forecast 2019-2028 Table of Contents 1. Market Introduction 1.1. Scope of Study 1.2. Problem Statement 1.3. Market Segmentation 2. Assumptions and Acronyms 3. Executive Summary 3.1. Global Market in 2022 3.2. Analyst Insights & Recommendations 3.3. Growth Opportunities and Key Strategies 3.4. Supply-side and Demand-side Trends 4. Research Methodology 5. Analysis of COVID-19 Impact and Road Ahead 6. Market Indicators and Background 6.1. Macro-Economic Factors 6.2. Forecasting Factors 6.3. Supply Chain & Value Chain Analysis 6.4. Industry SWOT Analysis 6.5. PESTLE Analysis 6.6. Porter's Five Forces Analysis 7. Government Laws and Industry Regulations 8. Global and Regional Market Dynamics 8.1. Drivers 8.2. Restraints 8.3. Trends 8.4. Opportunities 9. Parent Market Overview: Global Medical and Pharmaceutical Market 10. Segmental Analysis 10.1. Global Circulating Tumor Cell Market by Technology 10.1.1. Segment Overview 10.1.1.1. CTC Detection and Enrichment method 10.1.1.1.1. Immunocapture 10.1.1.1.2. Size Based Separation 10.1.1.1.3. Density-Based Separation 10.1.1.1.4. Combined Methods 10.1.1.1.5. Others 10.1.1.2. CTC Direct Detection Methods 10.1.1.2.1. SERS 10.1.1.2.2. Microscopy 10.1.1.2.3. Others 10.1.1.3. CTC Analysis 10.2. Global Circulating Tumor Cell Market by Application 10.2.1. Segment Overview 10.2.1.1. Clinical 10.2.1.2. Research 10.3. Global Circulating Tumor Cell Market by End User 10.3.1. Segment Overview 10.3.1.1. Hospitals and Clinics 10.3.1.2. Diagnostic Centers 10.3.1.3. Others 10.4. Global Circulating Tumor Cell Market by Region 10.4.1. North America 10.4.2. Latin America 10.4.3. Western Europe 10.4.4. Eastern Europe 10.4.5. Asia Pacific 10.4.6. Middle East & Africa 11. Regional Analysis 11.1. North America Circulating Tumor Cell Market Analysis and Forecast 2019-2028 11.1.1. Regional Market Overview and Key Takeaways 11.1.2. North America Circulating Tumor Cell Market by Application 11.1.3. North America Circulating Tumor Cell Market by Technology 11.1.4. North America Circulating Tumor Cell Market by End User Industry 11.1.5. North America Circulating Tumor Cell Market by Country 11.1.5.1. US 11.1.5.2. Canada 11.2. Latin America Circulating Tumor Cell Market Analysis and Forecast 2019-2028 11.2.1. Regional Market Overview and Key Takeaways 11.2.2. Latin America Circulating Tumor Cell Market by Application 11.2.3. Latin America Circulating Tumor Cell Market by Technology 11.2.4. Latin America Circulating Tumor Cell Market by End User Industry 11.2.5. Latin America Circulating Tumor Cell Market by Country 11.2.5.1. Brazil 11.2.5.2. Mexico 11.2.5.3. Rest of Latin America 11.3. Western Europe Circulating Tumor Cell Market Analysis and Forecast 2019-2028 11.3.1. Regional Market Overview and Key Takeaways 11.3.2. Western Europe Circulating Tumor Cell Market by Application 11.3.3. Western Europe Circulating Tumor Cell Market by Technology 11.3.4. Western Europe Circulating Tumor Cell Market by End User Industry 11.3.5. Western Europe Circulating Tumor Cell Market by Country 11.3.5.1. Germany 11.3.5.2. UK 11.3.5.3. France 11.3.5.4. Spain 11.3.5.5. Italy 11.3.5.6. Benelux 11.3.5.7. Nordic 11.3.5.8. Rest of Western Europe 11.4. Eastern Europe Circulating Tumor Cell Market Analysis and Forecast 2019-2028 11.4.1. Regional Market Overview and Key Takeaways 11.4.2. Eastern Europe Circulating Tumor Cell Market by Application 11.4.3. Eastern Europe Circulating Tumor Cell Market by Technology 11.4.4. Eastern Europe Circulating Tumor Cell Market by End User Industry 11.4.5. Eastern Europe Circulating Tumor Cell Market by Country 11.4.5.1. Russia 11.4.5.2. Poland 11.4.5.3. Rest of Eastern Europe 11.5. Asia Pacific Circulating Tumor Cell Market Analysis and Forecast 2019-2028 11.5.1. Regional Market Overview and Key Takeaways 11.5.2. Asia Pacific Circulating Tumor Cell Market by Application 11.5.3. Asia Pacific Circulating Tumor Cell Market by Technology 11.5.4. Asia Pacific Circulating Tumor Cell Market by End User Industry 11.5.5. Asia Pacific Circulating Tumor Cell Market by Country 11.5.5.1. China 11.5.5.2. Japan 11.5.5.3. India 11.5.5.4. South Korea 11.5.5.5. Australia 11.5.5.6. ASEAN 11.5.5.7. Rest of Asia-Pacific 11.6. Middle East & Africa Circulating Tumor Cell Market Analysis and Forecast 2019-2028 11.6.1. Regional Market Overview and Key Takeaways 11.6.2. Middle East & Africa Circulating Tumor Cell Market by Application 11.6.3. Middle East & Africa Circulating Tumor Cell Market by Technology 11.6.4. Middle East & Africa Circulating Tumor Cell Market by End User Industry 11.6.5. Middle East & Africa Circulating Tumor Cell Market by Country 11.6.5.1. GCC 11.6.5.2. South Africa 11.6.5.3. Turkey 11.6.5.4. Rest of the Middle East & Africa 12. Competitive Landscape 12.1. Competition Dashboard 12.1.1. Global and Regional Market Share Analysis 12.1.2. Market Structure 12.2. Competitive Benchmarking 12.3. Key Strategy Analysis 12.4. Company Profiles 12.4.1. Miltenyi Biotec 12.4.1.1. Company Overview 12.4.1.2. Product/Service Offerings 12.4.1.3. Financials 12.4.1.4. Recent Developments 12.4.2. Precision Medicine Group LLC 12.4.2.1. Company Overview 12.4.2.2. Product/Service Offerings 12.4.2.3. Financials 12.4.2.4. Recent Developments 12.4.3. Menarini Group 12.4.3.1. Company Overview 12.4.3.2. Product/Service Offerings 12.4.3.3. Key Financials 12.4.3.4. Recent Developments 12.4.4. SRI International, Biocept 12.4.4.1. Company Overview 12.4.4.2. Product/Service Offerings 12.4.4.3. Key Financials 12.4.4.4. Recent Developments 12.4.5. Inc., QIAGEN, Greiner AG 12.4.5.1. Company Overview 12.4.5.2. Product/Service Offerings 12.4.5.3. Financials 12.4.5.4. Recent Developments 12.4.6. Sysmex Corporation 12.4.6.1. Company Overview 12.4.6.2. Product/Service Offerings 12.4.6.3. Financials 12.4.6.4. Recent Developments 12.4.7. Thermo Fisher Scientific Inc. 12.4.7.1. Company Overview 12.4.7.2. Product/Service Offerings 12.4.7.3. Financials 12.4.7.4. Recent Developments 12.4.8. STEMCELL Technologies Inc. 12.4.8.1. Company Overview 12.4.8.2. Product/Service Offerings 12.4.8.3. Financials 12.4.8.4. Recent Developments A comprehensive list of Circulating Tumor Cell companies/providers by country will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities. 13. Disclaimer
Publisher: RationalStat
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support